Jiang Rensheng
- Jiang Rensheng chairs Shenzhen-listed vaccine firm Chongqing ZFSW Biological Products, known as Zhifei.
- A longtime distribution partner of Merck, Zhifei won the Chinese sales rights to the U.S. pharma’s HPV drug in 2018.
- The company is also developing its own tuberculosis vaccines.
- Prior to striking out on his own, he worked as a primary school teacher and a government health official.
